Saul Ramirez
Family · San Bernardino, CANPI 1043881691
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,561, 6.0 times the $591 reported in 2023. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $26.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$661
- Lilly USA, LLC$545
- Boehringer Ingelheim$500
- Otsuka America Pharmaceutical, Inc.$489
- Bayer$404
- plus $3K from 26 others
What the payments were for
- Food & beverage$6,459100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $1,056 |
| Novo Nordisk | 18 | $661 |
| Lilly USA, LLC | 34 | $545 |
| Boehringer Ingelheim | 19 | $500 |
| Otsuka America Pharmaceutical, Inc. | 10 | $489 |
| Bayer | 24 | $404 |
| Amgen | 13 | $344 |
| Novartis | 20 | $325 |
| Merck | 14 | $311 |
| Exact Sciences | 7 | $230 |
| Corcept Therapeutics | 10 | $197 |
| Johnson & Johnson(2 entities) | 2 | $172 |
| Axsome Therapeutics, Inc. | 1 | $141 |
| Neurocrine Biosciences, Inc. | 1 | $140 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Pfizer | 6 | $120 |
| Ardelyx, Inc. | 4 | $119 |
| GSK | 4 | $84 |
| Lexicon Pharmaceuticals, Inc. | 3 | $73 |
| Kowa Pharmaceuticals America, Inc. | 4 | $62 |
| Mylan Specialty L.p. | 3 | $58 |
| Shield Therapeutics Inc | 3 | $55 |
| Sanofi-aventis U.S. LLC | 3 | $46 |
| Abiomed | 1 | $37 |
| Astellas Pharma US Inc | 1 | $33 |
| Averitas Pharma Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Cequr Corporation | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,459 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Other family in San Bernardino
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.